Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Clinical trial NCT01947985 · COMPLETED

Trial details

NCT number: NCT01947985
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Venous Thrombosis Pulmonary Embolism Atrial Fibrillation Acute Coronary Syndrome

Start date: 2012-02-01
Primary completion: 2018-12-31
Enrollment: 208958

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.